Related Experiment Video
Updated: Aug 10, 2026

Vessel-sparing Excision and Primary Anastomosis
Published on: January 7, 2019
Urinary prostaglandin E2 excretion in chronic renal disease
Abstract:
To ascertain whether renal prostaglandin E2 production is impaired in chronic renal disease we measured urinary prostaglandin E2 in 25 female renal patiens, and in 38 female noirmal volunteers. Prostaglandin E2 averaged 337 +/- 63 ng/24 hr in 25 female renal patients, which was significantly higher (P < 0.01) than values in normal female subjects (166 +/- 17 ng/24 hr). None of the renal patients excreted less than 50 ng/24 hr, whereas normals when treated with indomethacin averaged 30 +/- 10 ng/24 hr (n=8). There were no significant correlations between prostaglandin E2 and creatinine clearance, or urine volume. No difference in prostaglandin E2 was encountered between hypertensive and normotensive renal patients. Our results indicate that renal prostaglandin E2 production is increased rather than decreased in renal disease. The failure to demonstrate decreased urinary prostaglandin E2 excretion in renal hypertension sharply contrasts with the situation in essential hypertension.
More Related Videos
Related Concept Videos
Drug Elimination by Renal Route: Tubular Secretion
Renal Drug Excretion: Glomerular Filtration
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles.
Renal Drug Excretion: Tubular Reabsorption
Renal Drug Excretion: Tubular Secretion
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

